Drug makers are fighting a rear-guard action against patent laws that are before the US Congress. Meredith Wadman reports.
Related links
Related links
Related links in Nature Research
Related external links
National Academy of Sciences 2004 report and recommendations on US patent reform
Rights and permissions
About this article
Cite this article
Wadman, M. Patent crunch pending. Nature 449, 651 (2007). https://doi.org/10.1038/449651a
Published:
Issue Date:
DOI: https://doi.org/10.1038/449651a